Leading Exosome Biotechnology Company Advances in Global Effort to Extend Healthy Human Lifespan MIRAMAR, Fla., May 12, 2025 /PRNewswire/ -- Kimera Labs, Inc., the pioneer in therapeutic ...

Synthego has expanded its CRISPR solutions portfolio with the launch of GMP SpCas9, offering researchers a powerful solution to enhance CRISPR-based therapeutic development. The launch of GMP SpCas9 ...

Stylus Medicine is unsheathing, penning a mission to develop next-gen in vivo genetic medicines with $85 million in hand, cofounder Patrick Hsu, Ph.D., told Fierce Biotech. | Stylus Medicine is ...

Researchers have discovered how to block cells dying, in a finding that could lead to new treatments for neurodegenerative conditions like Parkinson's and Alzheimer's. The team has identified a small ...

Eligo Bioscience, a biotechnology company pioneering the development of novel genetic medicines, today announced it has ...

The CAR-T industry is booming, with a significant surge in funding driven by successful therapies hitting the market. Over 170 companies are actively developing CAR-T products, with 1,944 therapies in ...

The chronic pruritus market is expected to grow across the 7MM, driven by the introduction of innovative therapies like ...

Financial Square Treasury Instruments Fund FST Shares FTIXX 29.42% Financial Square Government Fund FST Shares FGTXX 15.30% ...

The share buy-back program is undertaken in accordance with Regulation (EU) No. 596/2014 ('MAR') and the Commission Delegated Regulation (EU) 2016/1052, also referred to as the "Safe Harbour ...